11/09/2020

Clinical Pathways has exciting news to share about our new partnership with Metrics Champion Consortium (MCC), a division of WCG. MCC will now offer 12 new eLearning courses on performance management and good clinical practice (GCP) developed by Clinical Pathways to provide high-quality, effective training resources for clinical research stakeholders.

“When it comes to improving clinical trial performance through training and giving study teams the resources to do their jobs better, Clinical Pathways is a key thought leader for our industry,” said Linda Sullivan, MBA, executive director of MCC. “We’re excited to add more eLearning resources to the MCC Learning Institute to support GCP training and further develop the critical thinking skills needed to get to the root cause of issues and risks, and, in turn, drive meaningful performance and quality improvements across trial operations.”

Read more in the press release posted HERE.

About Metrics Champion Consortium
The Metrics Champion Consortium (MCC) is the leading life sciences industry consortium of community of practice groups dedicated to the development and adoption of standardized performance metrics and best-in-class risk/quality tools. The objective is achieved through the regular sharing of best practices and mitigation strategies to optimize and improve clinical trial conduct and management.

For more information, please visit: https://metricschampion.org/.

About WCG
WCG is the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. Comprised of two divisions – the industry’s first central IRB – WIRB-Copernicus IRB, and first clinical services organization (CSO) – WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protection. For more information, please visit https://www.wcgclinical.com/.

-The Clinical Pathways Team

Enjoy this blog? Please like, comment, and share with your contacts.